Viewing Study NCT00031772



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00031772
Status: COMPLETED
Last Update Posted: 2013-02-15
First Post: 2002-03-08

Brief Title: S9832 Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast Cancer
Sponsor: SWOG Cancer Research Network
Organization: SWOG Cancer Research Network

Study Overview

Official Title: Enhancing Well-Being During Breast Cancer Recurrence SWOG Study S9832
Status: COMPLETED
Status Verified Date: 2013-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE Telephone counseling by breast cancer survivors may enhance the well-being and quality of life of women who have recurrent breast cancer

PURPOSE Randomized clinical trial to study the effectiveness of telephone counseling by breast cancer survivors on the well-being of women who have recurrent breast cancer
Detailed Description: OBJECTIVES

Determine whether telephone counseling delivered by breast cancer survivors enhances the well-being of women with recurrent breast cancer
Determine the impact of sociodemographic clinical and psychosocial predictors of well-being in these patients
Determine the changes in well-being over time since disease recurrence in these patients

OUTLINE This is a randomized multicenter study Patients are stratified according to age under 50 vs 50 and over time since initial diagnosis less than 2 years vs 2 years or more and recurrence site soft tissue without bone vs soft tissue with bone vs visceral Patients are randomized to one of two study arms

Arm I control arm Patients receive the standard level of support by continuing to use existing resources Patients receive written materials from the counseling group at 6 months
Arm II intervention arm Patients receive weekly telephone counseling sessions by breast cancer survivors over 4 weeks for a total of 4-8 sessions Patients receive written materials from the counseling group after the first session

In both arms quality of life is assessed at baseline and at 3 and 6 months

PROJECTED ACCRUAL A total of 300 patients 150 per study arm will be accrued for this study within 30 months

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
U10CA037429 NIH NCI httpsreporternihgovquickSearchU10CA037429
S9832 OTHER None None
NCI-P02-0209 OTHER None None